A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate of long COVID.
On average, the pandemic caused low-income countries to experience an average progress loss of 16.5% across all health indicators, whereas high-income countries have seen losses as low as 3%, the authors said.
Extreme heat, spanning Lebanon to the Philippines since April, is being blamed for hundreds of deaths. It's added to the suffering of people who lack access to air conditioning, including displaced persons in the Middle East, the study notes.
Recent Comments